Skip to content
Trouble finding what you were looking for? We're here to help! Give us a call at 1300 938 637
Trouble finding what you were looking for? We're here to help! Give us a call at 1300 938 637

FlowArt Triple Lumen With Check Valve Anti Reflux

SKU FLO-A3010CV
Original price $5.90 - Original price $5.90
Original price
$5.90
$5.90 - $5.90
Current price $5.90

FlowArt Triple Lumen Needle Free Valve Connectors with One Directional Anti Reflux Check Valve.

FlowArt® Triple Lumen Check Valve is an extension set with needle-free valves which have fully transparent clear housing with an integrated flat silicone seal and one directional internal fluid pathway that protects the patient and nursing staff from exposures.

Quantity: 100 / Box

Product Code: FLO-A3010CV

Priming Volume: 0.75mL

Flow Rate: Up to 95mL/min

Length: 9.5cm

** Photoprotective version available upon request - Please use the Contact page to discuss further. 

Features:

  • Fully Transparent Valve
  • Gapless split septum seal
  • Flat closed seal that provides a swabable microbial barrier
  • Suitable for 7 days / 600 activations
  • Enhanced visualisation compared to opaque products
  • Compatible with Luer Slip and Luer Lock syringes
  • Free of PVC, latex and metals.
  • ISO 80369 standard compliant - Small-bore connectors for liquids and gases in healthcare applications
  • ISO 80369-7 standard compliant IV sets using luer lock connections.

    Suitable for:

    • Blood transfusion
    • Lipids
    • Oncology
    • MRI procedures
    • High flow rate infusions (Flowrate up to 95mL/min)

      Research:

      The prevalence of reported Needle Stick Injuries (NSIs) in Australia per year was estimated to be 18,000 in Australian hospitals alone before the introduction of Safety Engineered Devices (SEDs) [1-2]. Considering this number is only the reported incidences and underreporting in Australian hospitals is estimated to be 40%, [3] this is a significant hindrance in maintaining a safe work environment. There are a number of diseases that can be transmitted through NSI, including the human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV).  The use of SEDs has been shown to reduce NSIs by up to 31% during a 9-month implementation period. [4]

      1. Cathryn Murphy – (2008), Improved surveillance and mandated use of sharps with engineered sharp injury protections: a national call to action
      2. The Australian Council on Healthcare Standards - (2012) Infection Control version 3.1. Retrospective data in full. Australasian Clinical Indicator Report: 2004—2011. In (13th ed.). Sydney NSW; ACHS.
      3. Australian Safety and Compensation Council – (2008) Occupational Exposures in Australian Nurses. Canberra: Australian Government.
      4. Goris, Ashleigh J., Gemeinhart, Nancy, and Babcock, Hilary M - (2015) “Reducing Needlestick Injuries from Active Safety Devices: A Passive Safety Engineered Device Conversion.” AJIC: American Journal of Infection Control 43.6

      Additional Resources

      Request a quote